| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-06-18 15:19 Tx date 2026-06-17 |
$ONCO
Onco-Innovations Limited |
Mohamed, Islam G.
5 - Senior Officer of Issuer
Holder: ISLAM G MOHAMED MD MEDICAL CORPORATION (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+49,000 vol |
227,500 | |
| Filed 2026-06-18 15:19 Tx date 2026-06-02 |
$ONCO
Onco-Innovations Limited |
Mohamed, Islam G.
5 - Senior Officer of Issuer
Holder: ISLAM G MOHAMED MD MEDICAL CORPORATION (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,000 vol |
178,500 | |
| Older filings | ||||||
| Filed 2026-06-10 12:51 Tx date 2026-06-08 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,200
-14,000 vol $0.80 each |
678,300 | |
| Filed 2026-06-10 12:13 Tx date 2026-06-09 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,200
-14,000 vol $0.80 each |
||
| Filed 2026-06-07 00:10 Tx date 2026-06-05 |
$ONCO
Onco-Innovations Limited |
Antony, David Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2026-05-26 19:12 Tx date 2026-05-26 |
$ONCO
Onco-Innovations Limited |
Nico Mah
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+15,000 vol |
65,000 | |
| Filed 2026-05-26 19:11 Tx date 2026-05-26 |
$ONCO
Onco-Innovations Limited |
Nico Mah
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-15,000 vol |
55,000 | |
| Filed 2026-05-26 19:10 Tx date 2026-05-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+7,500 vol |
197,500 | |
| Filed 2026-05-26 19:10 Tx date 2026-05-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Rights
36 - Conversion or exchange
|
-7,500 vol |
22,500 | |
| Filed 2026-05-26 19:09 Tx date 2026-05-26 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+37,500 vol |
75,200 | |
| Filed 2026-05-26 19:08 Tx date 2026-05-26 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Rights
36 - Conversion or exchange
|
-37,500 vol |
262,500 | |
| Filed 2026-04-24 20:19 Tx date 2026-04-23 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,000
-10,000 vol $1.40 each |
692,300 | |
| Filed 2026-04-24 20:17 Tx date 2026-04-23 |
$ONCO
Onco-Innovations Limited |
O'Shaughnessy, Thomas Gerald
5 - Senior Officer of Issuer
Holder: Carnarvon Strategies - Health Industry Solutions Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,600
-10,000 vol $1.36 each |
702,300 | |
| Filed 2026-04-23 14:24 Tx date 2026-04-22 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,000
-20,000 vol $1.25 each |
190,000 | |
| Filed 2026-04-20 16:11 Tx date 2026-04-17 |
$ONCO
Onco-Innovations Limited |
Gulka, Christopher David
4 - Director of Issuer
Direct Ownership
|
Rights
30 - Acquisition or disposition under a purchase/ownership plan
|
+20,000 vol |
40,000 | |
| Filed 2026-04-20 15:12 Tx date 2026-04-17 |
$ONCO
Onco-Innovations Limited |
Nico Mah
5 - Senior Officer of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+10,000 vol |
70,000 | |
| Filed 2026-04-20 15:10 Tx date 2026-04-17 |
$ONCO
Onco-Innovations Limited |
Justus, Maximilian
4 - Director of Issuer
Holder: Sapphire Capital Strategies Inc. (Indirect Ownership)
|
Rights
56 - Grant of rights
|
+50,000 vol |
50,000 | |
| Filed 2026-04-20 15:10 Tx date 2024-11-26 |
$ONCO
Onco-Innovations Limited |
Justus, Maximilian
4 - Director of Issuer
Holder: Sapphire Capital Strategies Inc. (Indirect Ownership)
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-04-20 15:09 Tx date 2026-04-17 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Holder: 4076567 Canada Inc. (Indirect Ownership)
|
Rights
56 - Grant of rights
|
+50,000 vol |
50,000 | |
| Filed 2026-04-20 15:08 Tx date 2024-11-26 |
$ONCO
Onco-Innovations Limited |
Heinzl, Richard
4 - Director of Issuer
Holder: 4076567 Canada Inc. (Indirect Ownership)
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||